Vifor (International) AG et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.

Docket(#17) ANSWER to #1 Complaint, , COUNTERCLAIM against American Regent, Inc., Vifor (International) AG by Orbicular Pharmaceutical Technologies Pvt. Ltd..(Rovner, Philip) (Entered: 06/27/2025)

DocketCORRECTING ENTRY: Per counsel's request, the Main Documents of D.I. #14 , #15 , and #16 have been replaced to reflect the removal of language that indicated there is a jury demand. (mpb) (Entered: 06/27/2025)

Docket(#16) Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Orbicular Pharmaceutical Technologies Pvt. Ltd.. (Rovner, Philip) (Main Document 16 replaced on 6/27/2025) (mpb). (Entered: 06/26/2025)

Docket(#15) OPENING BRIEF in Support re #14 MOTION to Transfer Case to United States District Court for the District of New Jersey filed by Orbicular Pharmaceutical Technologies Pvt. Ltd..Answering Brief/Response due date per Local Rules is 7/10/2025. (Attachments: #1 Exhibit A-C)(Rovner, Philip) (Main Document 15 replaced on 6/27/2025) (mpb). (Entered: 06/26/2025)

Docket(#14) MOTION to Transfer Case to United States District Court for the District of New Jersey - filed by Orbicular Pharmaceutical Technologies Pvt. Ltd.. (Attachments: #1 Text of Proposed Order)(Rovner, Philip) (Main Document 14 replaced on 6/27/2025) (mpb). (Attachment 1 replaced on 6/27/2025) (mpb). (Entered: 06/26/2025)

Docket(#13) ORDER, granting #11 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey R. Gargano, A. Rebekah Hill and Adam S. Berlin. Signed by Judge William C. Bryson on 06/26/2025. (jfm) (Entered: 06/26/2025)

Docket(#12) Pro Hac Vice Fee - Credit Card Payment received for Jeffrey R. Gargano, A. Rebekah Hill, and Adam S. Berlin. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey R. Gargano, A. Rebekah Hill and Adam S. Berlin )( Payment of $ 150, receipt number ADEDC-4719679).(Rovner, Philip) (Entered: 06/25/2025)

Docket(#11) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey R. Gargano, A. Rebekah Hill and Adam S. Berlin - filed by Orbicular Pharmaceutical Technologies Pvt. Ltd.. (Rovner, Philip) (Entered: 06/25/2025)

DocketCase Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. Associated Cases: 1:25-cv-00211-CFC, 1:25-cv-00540-CFC (alb) (Entered: 06/25/2025)

DocketSO ORDERED, re #10 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiff's Complaint to June 27, 2025, filed by Orbicular Pharmaceutical Technologies Pvt. Ltd. Reset Answer Deadlines: Orbicular Pharmaceutical Technologies Pvt. Ltd. answer due 6/27/2025. Ordered by Judge Colm F. Connolly on 5/13/2025. (kmd) (Entered: 05/13/2025)

Docket(#9) STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) (Entered: 05/07/2025)

DocketCase Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmf) (Entered: 05/07/2025)

Docket(#8) DECLARATION of Service for Orbicular Pharmaceutical Technologies Pvt. Ltd. re #7 Summons Issued by American Regent, Inc., Vifor (International) AG. (Attachments: #1 Exhibit A-B)(Silver, Daniel) (Entered: 05/06/2025)

Docket(#7) Summons Issued as to Orbicular Pharmaceutical Technologies Pvt. Ltd. on 5/2/2025. (jfm) (Entered: 05/02/2025)

Docket(#6) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo, Inc., Other Affiliate Daiichi Sankyo Company, Limited, Other Affiliate Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. filed by American Regent, Inc. (jfm) (Entered: 05/02/2025)

Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CSL Limited for Vifor (International) AG filed by Vifor (International) AG. (jfm) (Entered: 05/02/2025)

Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,612,109; 7,754,702; 8,895,612; 11,433,091 ; 11,478,502. (jfm) (Entered: 05/02/2025)

Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/21/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/21/2027. (jfm) (Entered: 05/02/2025)

Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 05/02/2025)

Docket(#1) COMPLAINT for Patent Infringement against Orbicular Pharmaceutical Technologies Pvt. Ltd. (Filing fee $ 405, receipt number ADEDC-4677110) - filed by Vifor (International) AG, American Regent, Inc. (Attachments: #1 Exhibits A-E, #2 Civil Cover Sheet)(jfm) (Entered: 05/02/2025)